Finally, CML CD34+ cells cultured for 7 days in the presence of SFKs, MEK, and IKK inhibitors showed a normalizing effect on MAP3K8 transcript levels (Fig. 6B). The gene discussed is MAP3K8; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.